Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study

BackgroundMedication-overuse headache is highly prevalent in tertiary care centers. It may be a cause or consequence of the overuse of symptomatic medications for migraine attacks.ObjectiveWe aimed to compare the efficacy of anti-CGRP monoclonal antibodies (mAbs) added to conventional pharmacologica...

Full description

Bibliographic Details
Main Authors: Abouch V. Krymchantowski, Carla Jevoux, Ana Gabriela Krymchantowski, Raimundo Pereira Silva-Néto
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Neurology
Subjects:
chronic migraine
medication-overuse headache
monoclonal antibody
erenumab
galcanezumab
fremanezumab
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1129439/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1129439/full

Similar Items